OBESE CASTRATION-RESISTANT PROSTATE CANCER PATIENTS MAY BE AT A LOWER RISK OF METASTASIS AND ALL-CAUSE MORTALITY: RESULTS FROM THE SEARCH DATABASE

被引：0
|
作者：
Vidal, Adriana C.
Howard, Lauren E.
Kane, Christopher J.
Terris, Martha K.
Aronson, William J.
Cooperberg, Matthew R.
Amling, Christopher L.
Freedland, Stephen J.
机构：
来源：
JOURNAL OF UROLOGY | 2015年 / 193卷 / 04期
关键词：
D O I：
10.1016/j.juro.2015.02.874
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP14-12
引用
收藏
页码：E155 / E155
页数：1
相关论文
共 50 条
  • [21] Diagnosis of metastasis in castration-resistant prostate cancer patients: decision algorithm in imaging tests
    Juarez-Soto, A.
    Garin-Ferreira, J. M.
    Rodriguez-Fernandez, A.
    Tirado-Hospital, J. L.
    Gonzalez-Serrano, M. T.
    Moreno-Jimenez, J.
    Medina-Lopez, R.
    Baena-Gonzalez, V.
    ACTAS UROLOGICAS ESPANOLAS, 2019, 43 (02): : 55 - 61
  • [22] The UCSF cancer of the prostate risk assessment (CAPRA) score accurately predicts metastasis, prostate cancer mortality, and all-cause mortality regardless of treatment type
    Cooperberg, Matthew R.
    Broering, Jeannette M.
    Carroll, Peter R.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 114 - 115
  • [23] Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial
    Ferguson, Gary T.
    Singh, Dave
    Rabe, Klaus F.
    Jenkins, Martin
    Patel, Mehul
    Dorinsky, Paul
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [24] Treatment for castration-resistant prostate cancer and drug interaction risk in polymedicated patients
    Juarez Soto, A.
    ACTAS UROLOGICAS ESPANOLAS, 2020, 44 (10): : 641 - 643
  • [25] Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial
    Singh, D.
    Ferguson, T. G.
    Rabe, F. K.
    Jenkins, M.
    Patel, M.
    Dorinsky, P.
    PNEUMOLOGIE, 2022, 76 : S6 - S7
  • [26] Association of prostate-specific antigen (PSA) trajectories with risk for metastasis and mortality in non-metastatic castration-resistant prostate cancer (nmCRPC).
    Li, Sophia
    Ding, Zhijie
    Lin, Jennifer H.
    Behl, Ajay S.
    Pericone, Chris
    Macomson, Brian
    Shore, Neal D.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [27] Association of prostate-specific antigen (PSA) trajectories with risk for metastasis and mortality in non-metastatic castration-resistant prostate cancer (nmCRPC).
    Li, Sophia
    Ding, Zhijie
    Lin, Jennifer H.
    Behl, Ajay S.
    Pericone, Chris
    Macomson, Brian
    Shore, Neal D.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [28] Burden of illness of chemotherapy in castration-resistant prostate cancer patients in Japan: a retrospective database analysis
    Mahlich, Joerg
    Tsubota, Akiko
    Imanaka, Keiichiro
    Enjo, Kentaro
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (10) : 1855 - 1860
  • [29] In Men with Castration-Resistant Prostate Cancer, Visceral Metastases Predict Shorter Overall Survival: What Predicts Visceral Metastases? Results from the SEARCH Database
    Whitney, Colette A.
    Howard, Lauren E.
    Posadas, Edwin M.
    Amling, Christopher L.
    Aronson, William J.
    Cooperberg, Matthew R.
    Kane, Christopher J.
    Terris, Martha K.
    Freedland, Stephen J.
    EUROPEAN UROLOGY FOCUS, 2017, 3 (4-5): : 480 - 486
  • [30] IN MEN WITH CASTRATION-RESISTANT PROSTATE CANCER VISCERAL METASTASES PREDICTS SHORTER OVERALL SURVIVAL: WHAT PREDICTS VISCERAL METASTASES? RESULTS FROM THE SEARCH DATABASE
    Whitney, Colette
    Howard, Lauren
    Posadas, Edwin
    Amling, Christopher
    Aronson, William
    Cooperberg, Matthew
    Kane, Christopher
    Terris, Martha
    Freedland, Stephen
    JOURNAL OF UROLOGY, 2017, 197 (04): : E455 - E455
12345